Patient preferences for oropharyngeal cancer treatment de-escalation-Reference-Cited by-同舟云学术

Patient preferences for oropharyngeal cancer treatment de-escalation

Published:2012-03-20 Issue:2 Volume:35 Page:151-159
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head Neck

Author:

Brotherston Drew C.,Poon Ian,Le Tuyen,Leung Martin,Kiss Alex,Ringash Jolie,Balogh Judith,Lee Justin,Wright James R.

Publisher

Wiley

Subject

Otorhinolaryngology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hed.22930/fullpdf

Reference54 articles.

1. Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized study;Lo;AJR Am J Roentgenol,1976

2. Human papillomavirus and survival of patients with oropharyngeal cancer;Ang;N Engl J Med,2010

3. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial;Fakhry;J Natl Cancer Inst,2008

4. Human papillomavirus infection as a prognostic factor in oropharyngeal squamous cell carcinomas treated in a prospective phase II clinical trial;Jo;Anticancer Res,2009

5. Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial;Kies;J Clin Oncol,2010

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Less is more: Exploring neoadjuvant immunotherapy as a de-escalation strategy in head and neck squamous cell carcinoma treatment;Cancer Letters;2024-08

2. CompARE: study protocol for a phase III randomised controlled platform trial comparing alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer;Trials;2024-01-15

3. De-escalating radiotherapy in HPV-positive oropharyngeal squamous cell carcinoma: how much is too little?;BMJ Case Reports;2024-01

4. Challenges in primary treatment of older patients with head and neck cancer;Die Onkologie;2023-09-29

5. Lessons and Opportunities for Biomarker-Driven Radiation Personalization in Head and Neck Cancer;Seminars in Radiation Oncology;2023-07